DOLUTEGRAVIR ETHYL ETHER (25 mg) ((4R,12aS)-N-(2,4-difluorobenzyl)-7-ethoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide )

DOLUTEGRAVIR ETHYL ETHER (25 mg) ((4R,12aS)-N-(2,4-difluorobenzyl)-7-ethoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide )

In Stock

Ready to ship

Catalogue No.

1A12910

CAS No.

1802141-49-6

Molecular Formula

C₂₂H₂₃F₂N₃O₅

Product Type

Pharmaceutical Analytical Impurities

$1,250.00

Shipping information

Click Here to learn more about Pharmaceutical Analytical Impurities (PAI). PAI products are different from official USP Reference Standards. This material is an Analytical Material and not a USP Reference Standard.

Additional information

Additional information

Current Lot Information

Current Lot:

F267T0

CAS RN®

1802141-49-6

Harmonized System (HS) Code *:

29349990

UN No:

N/A

NDC No:

N/A

Molecular Formula

C₂₂H₂₃F₂N₃O₅

Container Type:

VIAL

Base Control Substance (substance %):

N | A

Product Information

SDS:

USP Certificates/Product Information Sheets and Valid Use Dates

Lot No	USP Certificates/Product Information Sheets and Valid Use Dates	Valid Use Date	Country of Origin*	Material Origin*
F267T0	1A12910-F267T0	See Product Information Sheet	India	Chemical Synthesis


Lot No F267T0	USP Certificates/Product Information Sheets and Valid Use Dates Chemical Synthesis
Valid Use Date See Product Information Sheet
Country of Origin* India
Material Origin* No data available

Lot No

F267T0

USP Certificates/Product Information Sheets and Valid Use Dates

Chemical Synthesis

Valid Use Date

See Product Information Sheet

Country of Origin*

India

Material Origin*

No data available

Frequently bought together

DOLUTEGRAVIR ETHYL ETHER (25 mg) ((4R,12aS)-N-(2,4-difluorobenzyl)-7-ethoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide )

Catalogue No.

1A12910

CAS No.

1802141-49-6

Molecular Formula

C₂₂H₂₃F₂N₃O₅

Product Type

Pharmaceutical Analytical Impurities

$1,250.00

PIVALOYL PHENYLGLYCINE (25 mg) ((R)-2-Phenyl-2-pivalamidoacetic acid)

Catalogue No.

1A10150

CAS No.

40610-41-1

Molecular Formula

C₁₃H₁₇NO₃

Product Type

Pharmaceutical Analytical Impurities

$525.00

DEPROPYLAMINO HYDROXY PROPAFENONE (25 mg) (1-[2-[(2RS)-2,3-Dihydroxypropoxy]phenyl]-3-phenylpropan-1-one)

Catalogue No.

1A09940

CAS No.

91401-73-9

Molecular Formula

C₁₈H₂₀O₄

Product Type

Pharmaceutical Analytical Impurities

$750.00

OMEPRAZOLE DIHYDROPYRIDINE (25 mg) (1-(5-Methoxy-1H-benzimidazol-2-yl)-3,5-dimethyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid )

11-CHLORO BECLOMETHASONE DIPROPIONATE (25 mg) (9,11?-Dichloro-16?-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropionate)

N-ETHYL ESMOLOL (25 mg) (Methyl 3-{4-[3-(ethylamino)-2-hydroxypropoxy]phenyl}propionate)

NONACOSANE (100 mg) (Nonacosane)

PIRFENIDONE DIMER (25 mg) (1,1'-(1,4-Phenylene)bis(5-methylpyridin-2(1H)-one))

LEVOTHYROXINE BENZAMIDE (25 mg) (4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodobenzamide)

4-NITROIMIDAZOLEETHANOL (25 mg) (2-(4-nitro-1H-imidazol-1-yl)ethanol )

R-GLYCIDYL LINEZOLID (25 mg) ((R)-3-Fluoro-4-morpholino-N-(oxiran-2-ylmethyl)aniline )

RISPERIDONE CIS-N-OXIDE MONOHYDRATE (25 mg) (cis-3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, N-oxide monohydrate)

2,6-DIFLUORO DOLUTEGRAVIR (25 mg) ((4R,12aS)-N-(2,6-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide )